BSE
Your Result on : Company News Details
Concord Biotech Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543960
ISIN Demat
INE338H01029
Book Value (Rs)
99.7123352
NSE Symbol
CONCORDBIO
Divident Yield %
0.63
Market Cap
(Rs In Cr.)
12,439
P/E (TTM)
41.87
EPS (TTM)
14.2
Face Value
(Rs)
1
Back
Concord Biotech consolidated net profit rises 11.12% in the September 2026 quarter
28-Oct-26   Hrs IST

Net profit of Concord Biotech rose 11.12% to Rs 70.65 crore in the quarter ended September 2026 as against Rs 63.58 crore during the previous quarter ended September 2025. Sales rose 25.10% to Rs 309.07 crore in the quarter ended September 2026 as against Rs 247.06 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales309.07247.06 25
OPM %33.5635.82 -
PBDT113.86104.08 9
PBT95.4885.68 11
NP70.6563.58 11

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
BSE Delayed market data sourced at 5 minutes – www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed , Maintained and Content Powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)